Nicorette Mint (Nicotine Resinate)

Nicotine Resinate, the active ingredient in Nicorette Mint, is a nicotine replacement therapy presented as a mint‑flavored oromucosal product for oral use. It helps adult smokers manage withdrawal symptoms and cravings associated with quitting tobacco. GNH USA supplies Nicorette Mint as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicotine Resinate in Nicorette Mint is used in nicotine replacement therapy to aid smoking cessation.

Smoking cessation: provides controlled nicotine to reduce cravings and withdrawal. Nicotine dependence: supplies low‑level nicotine to support gradual reduction. Tobacco use disorder: assists adults who wish to quit smoking by mitigating withdrawal effects.

Nicotine Resinate may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Mouth irritation or soreness - Nausea or upset stomach - Headache - Dizziness or light‑headedness - Hiccups - Insomnia or disturbed sleep

Serious or Rare Side Effects: - Allergic reaction (rash, swelling, difficulty breathing) - Chest pain or palpitations - Irregular heart rhythm - Severe hypotension - Persistent vomiting - Unexplained fainting

Before using Nicorette Mint, consider the following safety measures.

Cardiovascular assessment: evaluate recent heart attack or unstable angina. Pregnancy and lactation: avoid unless benefits outweigh risks and prescriber advises. Duration of therapy: do not exceed recommended treatment period without medical review. Concomitant nicotine sources: avoid using other nicotine products simultaneously. Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Nicotine Resinate can interact with several medicines; awareness helps prevent complications.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may increase risk of hypertensive crisis. - Certain antihypertensives: nicotine can counteract blood‑pressure‑lowering effects.

Moderate Interactions (Monitor Closely): - Insulin or oral hypoglycemics: nicotine may affect glucose control, requiring dose adjustments. - Psychiatric medications (e.g., antipsychotics): nicotine can alter plasma levels. - Caffeine‑containing products: may enhance stimulant effects, leading to jitteriness.